Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antioxidant drugs combined with alpha-interferon in chronic hepatitis C not responsive to alpha-interferon alone: a randomized, multicentre study.
Idéo G, Bellobuono A, Tempini S, Mondazzi L, Airoldi A, Benetti G, Bissoli F, Cestari C, Colombo E, Del Poggio P, Fracassetti O, Lazzaroni S, Marelli A, Paris B, Prada A, Rainer E, Roffi L. Idéo G, et al. Among authors: airoldi a. Eur J Gastroenterol Hepatol. 1999 Nov;11(11):1203-7. doi: 10.1097/00042737-199911000-00003. Eur J Gastroenterol Hepatol. 1999. PMID: 10563527 Clinical Trial.
A pilot study of thymosin-alpha 1 therapy for chronic hepatitis D.
Zavaglia C, Bottelli R, Smedile A, Iamoni G, Mondazzi L, Airoldi A, Lanzani F, Idéo G. Zavaglia C, et al. Among authors: airoldi a. J Clin Gastroenterol. 1996 Sep;23(2):162-3. doi: 10.1097/00004836-199609000-00024. J Clin Gastroenterol. 1996. PMID: 8877652 Clinical Trial. No abstract available.
Intramuscular beta interferon for chronic hepatitis C: is it worth trying?
Fesce E, Airoldi A, Mondazzi L, Maggi G, Gubertini G, Bernasconi G, Del Poggio P, Bozzetti F, Idéo G. Fesce E, et al. Among authors: airoldi a. Ital J Gastroenterol Hepatol. 1998 Apr;30(2):185-8. Ital J Gastroenterol Hepatol. 1998. PMID: 9675656 Clinical Trial.
Antiviral therapy of HBV- and HCV-induced liver cirrhosis.
Zavaglia C, Airoldi A, Pinzello G. Zavaglia C, et al. Among authors: airoldi a. J Clin Gastroenterol. 2000 Apr;30(3):234-41. doi: 10.1097/00004836-200004000-00006. J Clin Gastroenterol. 2000. PMID: 10777179 Review.
Lack of a strong association between HLA class II, tumour necrosis factor and transporter associated with antigen processing gene polymorphisms and virological response to alpha-interferon treatment in patients with chronic hepatitis C.
Airoldi A, Zavaglia C, Silini E, Tinelli C, Martinetti M, Asti M, Rossini A, Vangeli M, Salvaneschi L, Pinzello G. Airoldi A, et al. Eur J Immunogenet. 2004 Dec;31(6):259-65. doi: 10.1111/j.1365-2370.2004.00478.x. Eur J Immunogenet. 2004. PMID: 15548263
Adverse events affect sorafenib efficacy in patients with recurrent hepatocellular carcinoma after liver transplantation: experience at a single center and review of the literature.
Zavaglia C, Airoldi A, Mancuso A, Vangeli M, Viganò R, Cordone G, Gentiluomo M, Belli LS. Zavaglia C, et al. Among authors: airoldi a. Eur J Gastroenterol Hepatol. 2013 Feb;25(2):180-6. doi: 10.1097/MEG.0b013e328359e550. Eur J Gastroenterol Hepatol. 2013. PMID: 23044808 Review.
97 results